Product Information

DARIFENACIN ER 15 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.3971 per EA under NDC 69097043205. Its NADAC has been published 509 times since Nov 23, 2016.

FDA first approved this application on Sep 1, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DARIFENACIN ER 15 MG TABLET

Darifenacin Hydrobromide
$0.3971per EA

Strength

15 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097043205

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DARIFENACIN HYDROBROMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207664

FDA Approved

9/1/2016

TE Code

AB

On Market Since

9/1/2016

Pharmacological Classes

Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for DARIFENACIN ER 15 MG TABLET has been published 509 times since Nov 23, 2016, and over the history we have for it it has declined 95.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3971 per EA
All-time high$8.1286 (Feb 15, 2017)
All-time low$0.3150 (Mar 19, 2025)
52-week high$0.4517
52-week low$0.3496
Median price$2.0143
Average price$2.7233
Largest weekly change+137.4% (Jun 23, 2021)
Weeks tracked509
Tracking sinceNov 23, 2016

Price History

1W

+4.8%

1M

+4.8%

3M

-6.5%

6M

-0.1%

1Y

-12.1%

3Y

-71.1%

5Y

-80.3%

All

-95.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of DARIFENACIN ER 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DARIFENACIN ER 15 MG TABLET, manufactured by Cipla USA Inc., is $0.3971 per EA (NDC 69097043205), effective Aug 19, 2026.

How has the price of DARIFENACIN ER 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for DARIFENACIN ER 15 MG TABLET has declined 95.0%. It has been tracked across 509 weekly CMS publications since Nov 23, 2016.

What are the highest and lowest recorded NADAC prices for DARIFENACIN ER 15 MG TABLET?

Since Nov 23, 2016, the NADAC for DARIFENACIN ER 15 MG TABLET has ranged from a low of $0.3150 (Mar 19, 2025) to a high of $8.1286 (Feb 15, 2017), with a median of $2.0143 per EA.

Are there cheaper alternatives to DARIFENACIN ER 15 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DARIFENACIN ER 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures DARIFENACIN ER 15 MG TABLET?

DARIFENACIN ER 15 MG TABLET (NDC 69097043205) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.